Nonetheless, PK/PD identified successful CNS penetration of NVS‐PAK1‐1 in the 5xFAD AD model, and a reduction in brain PAK1 activity, reinforcing potential for further preclinical development. The gene discussed is PAK1; the disease is Alzheimer disease.